Arbutus Biopharma Corporation (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.17
-2.69%
Mkt Cap $830.78M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+104.1%
Consensus $8.50 vs current $4.17
NASDAQ·Healthcare·Biotechnology
$4.17
-2.69%
Mkt Cap $830.78M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+104.1%
Consensus $8.50 vs current $4.17